Recently, in the bile duct ligation-induced liver cirrhosis (Sever et al., 2019), no portal hypertension development and reversal of the already preexisting portal hypertension to normal values (Sever et al., 2019) have become possible
Blood 128 , 121121 (2016)
Although limited, clinical evidence suggests benefits on metabolic parameters and cardiovascular risk factors
Researchers have also examined its effects on gut epithelial and endothelial models in the context of gastrointestinal barrier research (Sikiric et al., 2025, Pharmaceuticals)
Aging 36, 22602271
unpacks this category further: Liver Support: Since rosuvastatin is metabolised in the liver, maintaining high levels of the liver's primary antioxidant can be a proactive way to support organ health